Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy STAT 15h Novartis Pharma Science
Belfast biotech firm re-engages with global pharmaceutical business for ramp project Insider Media 2d Biotechnology Pharma
CBI FIR against waste management company Hanjer Biotech for defrauding bank of $10 million under guise of setting up recycling plant in UK; 2nd fraud case The Times of India 2d Biotech Biotechnology
AbbVie bolsters UK R&D presence, inks $1.38bn IBD deal with Nxera Pharmaceutical Technology 4d Nxera Pharma Biotech All sources
Prediction: AbbVie's next blockbuster is hiding in a two-drug Crohn's combo The Motley Fool 6d Pharma All sources
AbbVie’s skin disease drug posts Phase III win as market competition heats up Clinical Trials Arena 12:57 Fri, 23 Oct Phase III Biotech Pharma
